Actelion SWOT Analysis
Actelion is one of the leading brands in the pharma and healthcare sector. Actelion SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of Actelion:
Quick Glance:
Actelion Strengths
- Actelion operates in niche segment of orphan diseases which have less competition
- Strong presence in over 60 plus markets
- Key drugs in the late stages of development in pipeline
- Longer patent life of key drugs
- Over 2500+ well trained employees
Above are the strengths in the SWOT Analysis of Actelion. The strengths of Actelion looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Actelion Weaknesses
- Limited presence in emerging markets
- They have only four blockbuster drugs
These were the weaknesses in the Actelion SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Actelion Opportunities
- Diversify portfolio in specialty diseases
- Contract manufacturing of G.P diseases
- Market introduction of Cadazolid
Above we covered the opportunities in Actelion SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Actelion Threats
- Increasing pressure to reduce prices in Europe
- Growing number of generic drugs
- Global economic slowdown
The threats in the SWOT Analysis of Actelion are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Read Similar SWOT analysis
Hence this concludes the Actelion SWOT analysis.
Continue reading more about the brand/company.
About Actelion
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Actelion Overview | |
|---|---|
| Parent Company |
Actelion |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Together we innovate |
| USP |
Actelion operates in niche segment of orphan diseases |
| Actelion STP | |
| Segmentation |
Orphan diseases such as digital ulcers, gaucher’s disease |
| Target Market |
Healthcare professionals operating in these areas |
| Positioning |
Actelion is company which blends biotechnological innovation with pharmaceutical discipline |
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Browse marketing analysis of more brands and companies similar to Actelion. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
